Alan raises €480M as healthtech consolidation accelerates
French health insurance company Alan agreed a €480M funding round valuing the business at €5.5B.
European healthtech is still producing large growth rounds when the company has scale, recurring revenue and a clear healthcare workflow. Alan’s new financing puts it firmly in that category.
What happened
French health insurance company Alan agreed a €480M funding round valuing the company at €5.5B.
The round is led by Prosus, with participation from existing shareholders Teachers’ Venture Growth and Index Ventures, plus new investor Dara Holdings. Alan says it has more than 1.1M customers and over €800M ARR in Q1 2026.
Why it matters
This is the strongest European healthtech funding signal in this batch.
Alan is no longer just a digital insurance challenger. It is building a broader health platform with insurance, healthcare services, product innovation and potential acquisition activity.
The bigger picture
Healthtech winners may consolidate around platforms that combine distribution, regulated infrastructure and AI-enabled services. The hard part is not only building better software, but operating inside complex healthcare systems at scale.